Literature DB >> 24898580

ABO-incompatible heart transplants.

M Hageman1, N Michaud2, I Chinnappan3, T Klein3, B Mettler3.   

Abstract

A month-old baby girl with blood type O positive received a donor heart organ from a donor with blood type B. This was the first institutional ABO-incompatible heart transplant. Infants listed for transplantation may be considered for an ABO-incompatible heart transplant based on their antibody levels and age. The United Network of Organ Sharing (UNOS) protocol is infants under 24 months with titers less than or equal to 1:4.(1) This recipient's anti-A and anti-B antibodies were monitored with titer assays to determine their levels; antibody levels less than 1:4 are acceptable pre-transplant in order to proceed with donor and transplant arrangements.1 Immediately prior to initiating cardiopulmonary bypass (CPB), a complete whole body exchange transfusion of at least two-times the patient's circulating blood volume was performed with packed red blood cells (pRBC), fresh frozen plasma (FFP) and 25% albumin. Titer assays were sent two minutes after initiation of full CPB and then hourly until the cross-clamp was removed. Institutionally, reperfusion of the donor heart is not restored until the antibody level from the titer assay is known and reported as less than 1:4; failing to achieve an immulogically tolerant recipient will provide conditions for hyperacute rejection. The blood collected during the transfusion exchange was immediately processed through a cell saver so the pRBC's could be re-infused to the patient during CPB, as necessary. The remainder of the transplant was performed in the same fashion as an ABO-compatible heart transplant. The patient has shown no signs of rejection following transplantation.
© The Author(s) 2014.

Entities:  

Keywords:  ABO-incompatible; heart; pediatric; perfusion; transplantation

Mesh:

Substances:

Year:  2014        PMID: 24898580     DOI: 10.1177/0267659114538895

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  1 in total

1.  ABO antibody titres: a multisite comparative study of equivalency and reproducibility for automated solid-phase and haemagglutination titration, and manual dilution with gel column agglutination technology.

Authors:  Dana Schneider; Mariangela Vicarioto; Serelina Coluzzi; Antonella Matteocci; Nicoletta Revelli; Barbara Foglieni; Patrizia Artusi; Donatella Londero; Anna Quaglietta; Giancarla Barrotta; Domenico Visceglie; Giuseppina Portararo; Jonella Gilsdorf
Journal:  Blood Transfus       Date:  2022-01-20       Impact factor: 5.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.